{"data":[{"event_id":990101,"catalyst_id":990001,"event_type":"new_date_assigned","drug_name":"SAMPLIMAB","company":"Sample Therapeutics, Inc.","ticker":"XSMPL","tickers":["XSMPL","XPRTN"],"indication":"sample indication (moderate-to-severe examplitis)","application_number":"BLA999901","prior_date":null,"new_date":"2026-04-18","new_date_upcoming":false,"days_to_date":null,"delta_days":null,"merged_into":null,"outcome":null,"confidence":"high","date_confidence":"confirmed","authority":"llm_high","source_quote":"The FDA has assigned a PDUFA target action date of April 18, 2026 for SAMPLIMAB. [FICTIONAL SAMPLE — not a real filing sentence]","detected_at":"2025-11-03T13:41:09.000000+00:00","filed_at":"2025-11-03","applied":true,"date_changed":true,"accession":"0009999001-25-000090","source_url":"https://www.sec.gov/Archives/edgar/data/9999001/000999900125000090/0009999001-25-000090-index.htm"},{"event_id":990102,"catalyst_id":990001,"event_type":"date_extension","drug_name":"SAMPLIMAB","company":"Sample Therapeutics, Inc.","ticker":"XSMPL","tickers":["XSMPL","XPRTN"],"indication":"sample indication (moderate-to-severe examplitis)","application_number":"BLA999901","prior_date":"2026-04-18","new_date":"2026-06-12","new_date_upcoming":false,"days_to_date":null,"delta_days":55,"merged_into":null,"outcome":null,"confidence":"high","date_confidence":"confirmed","authority":"llm_high","source_quote":"The FDA extended the PDUFA target action date for SAMPLIMAB to June 12, 2026. [FICTIONAL SAMPLE — not a real filing sentence]","detected_at":"2026-02-14T08:22:51.000000+00:00","filed_at":"2026-02-14","applied":true,"date_changed":true,"accession":"0009999001-26-000015","source_url":"https://www.sec.gov/Archives/edgar/data/9999001/000999900126000015/0009999001-26-000015-index.htm"},{"event_id":990103,"catalyst_id":990001,"event_type":"decision_outcome","drug_name":"SAMPLIMAB","company":"Sample Therapeutics, Inc.","ticker":"XSMPL","tickers":["XSMPL","XPRTN"],"indication":"sample indication (moderate-to-severe examplitis)","application_number":"BLA999901","prior_date":null,"new_date":"2026-06-12","new_date_upcoming":false,"days_to_date":null,"delta_days":null,"merged_into":null,"outcome":"crl","confidence":"high","date_confidence":"confirmed","authority":"llm_high","source_quote":"The company received a Complete Response Letter from the FDA regarding the Biologics License Application for SAMPLIMAB. [FICTIONAL SAMPLE — not a real filing sentence]","detected_at":"2026-06-13T11:05:30.000000+00:00","filed_at":"2026-06-13","applied":true,"date_changed":false,"accession":"0009999001-26-000031","source_url":"https://www.sec.gov/Archives/edgar/data/9999001/000999900126000031/0009999001-26-000031-index.htm"},{"event_id":990104,"catalyst_id":990002,"event_type":"corrected","drug_name":"EXTENDIVIR","company":"Extendia Pharma plc","ticker":"XEXTD","tickers":["XEXTD"],"indication":"sample indication (chronic placeholder syndrome)","application_number":"NDA999902","prior_date":"2026-11-02","new_date":"2026-11-16","new_date_upcoming":true,"days_to_date":107,"delta_days":14,"merged_into":null,"outcome":null,"confidence":"high","date_confidence":"confirmed","authority":"human_lock","source_quote":"Vendor data repair: the served date was corrected to the date asserted by the newest filing. This is not an FDA action. [FICTIONAL SAMPLE — not a real filing sentence]","detected_at":"2026-07-21T09:15:00.000000+00:00","filed_at":null,"applied":true,"date_changed":true,"accession":"correction:990002:2026-07-21T09:15:00+00:00","source_url":null},{"event_id":990105,"catalyst_id":990001,"event_type":"new_date_assigned","drug_name":"SAMPLIMAB","company":"Sample Therapeutics, Inc.","ticker":"XSMPL","tickers":["XSMPL","XPRTN"],"indication":"sample indication (moderate-to-severe examplitis)","application_number":"BLA999901","prior_date":null,"new_date":"2026-04-18","new_date_upcoming":false,"days_to_date":null,"delta_days":null,"merged_into":null,"outcome":null,"confidence":"high","date_confidence":"confirmed","authority":"llm_high","source_quote":"The FDA has assigned a PDUFA target action date of April 18, 2026 for SAMPLIMAB. [FICTIONAL SAMPLE — not a real filing sentence]","detected_at":"2026-07-30T09:00:00.000000+00:00","filed_at":"2025-10-01","applied":false,"date_changed":false,"accession":"0009999001-25-000091","source_url":"https://www.sec.gov/Archives/edgar/data/9999001/000999900125000091/0009999001-25-000091-index.htm"},{"event_id":990106,"catalyst_id":990003,"event_type":"retracted","drug_name":"SAMPLIMAB","company":"Duplicate Filer Royalty Corp.","ticker":"XDUPE","tickers":["XDUPE"],"indication":null,"application_number":null,"prior_date":null,"new_date":null,"new_date_upcoming":false,"days_to_date":null,"delta_days":null,"merged_into":990001,"outcome":null,"confidence":"high","date_confidence":"confirmed","authority":"llm_high","source_quote":"Merged into catalyst 990001 — a co-filer's record of the same FDA decision. Re-point to catalyst_id 990001. [FICTIONAL SAMPLE — not a real filing sentence]","detected_at":"2026-07-25T10:00:00.000000+00:00","filed_at":null,"applied":false,"date_changed":false,"accession":"lifecycle:2026-07-25T10:00:00+00:00","source_url":null}],"meta":{"total":6,"limit":100,"next_since":990106,"has_more":false}}